Creating novel microbiome-based interventions to retrain the immune system to become tolerant against disease with an initial focus on curing and preventing pediatric atopy
Location: United States, Massachusetts, Boston
Employees: 1-10
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | AllerFund | allerfund.... |
| - | Ariel Sava... | asap-inves... |
Mentions in press and media 3
| Date | Title | Description |
| 28.02.2014 | 5 Considerations for Synthetic Biology Investors — By Jamie Bacher | This post originally appeared on SynBioBeta on February 26th, 2014 Dr. Jamie Bacher is the founder and CEO of Pareto Biotechnologies. He previously served as Deputy Program Manager and led an 80 employee, $100 million project for Total New ... |
| 04.12.2013 | Peter Thiel's Breakout Labs sees first exit validation | Chalk one up for Peter Thiel's two-year-old accelerator for tough science problems For every accelerator or incubator, or VC for that matter, the way to meausre their success is to look at their exits. So when they come, it's always time to... |
| 14.11.2013 | Pareto Biotechnologies Raises Funding from Breakout Labs | Pareto Biotechnologies, a San Francisco, CA-based a synthetic biology startup, raised funding from Breakout Labs. The amount of the transaction was not disclosed. The company intends to use the funds to develop a portfolio of designer molec... |